A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
for Non-Hodgkin Lymphoma
Drug: Epcoritamab
18 locations incl. Tucson
Sponsor: Genmab
Sex: All·Age: 18+
Code: NCT05283720·Phase 2·Recruiting